Table 3

Organization and establishment

Characteristics
Organizations producing CPGs (n = 31)
Organizations producing HTAs (n = 19)
Organizations producing CPGs and HTAs (n = 45)
Organizations supporting government policymaking (n = 57)

Type of product produced

Reported also providing direct support to policymakers for developing health policy
17 (55%)
16 (85%)
35 (78%)
-
Reported also producing clinical practice guidelines
-
-
-
17 (30%)
Reported also producing HTAs
-
-
-
11 (19%)

Types of services undertaken in response to requests from public policymakers*

Identify primary research
-
-
-
36 (63%)
Identify systematic reviews of research
-
-
-
31 (54%)
Identify clinical practice guidelines, HTAs or other prescriptive research-based documents
-
-
-
24 (42%)
Undertake short-term research projects
-
-
-
45 (79%)
Undertake systematic reviews of research
-
-
-
38 (67%)
Commission systematic reviews of research
-
-
-
17 (30%)
Either undertake systematic reviews of research or commission systematic reviews of research
-
-
-
41 (72%)
Convene expert meetings to discuss available research
-
-
-
47 (82%)
Other
-
-
-
18 (32%)

Type of organization

Academic institution
7 (23%)
7 (37%)
11 (24%)
21 (37%)
Disease-specific association
1 (3%)
0 (0%)
1 (2%)
0 (0%)
Professional association
14 (45%)
2 (11%)
4 (9%)
3 (5%)
Government agency
9 (29%)
12 (63%)
22 (49%)
22 (39%)
International agency
0 (0%)
0 (0%)
3 (7%)
7 (12%)
Other
8 (26%)
2 (11%)
7 (16%)
18 (32%)

Source of funding*

Biomedical or other for-profit company
7 (23%)
1 (5%)
6 (13%)
6 (11%)
Government
17 (55%)
18 (95%)
38 (84%)
45 (79%)
Other
15 (48%)
3 (16%)
20 (44%)
38 (67%)

Examples from other countries helpful in establishing the organization

Yes
18 (58%)
14 (74%)
24 (53%)
30 (53%)
No
8 (26%)
0 (0%)
15 (33%)
17 (30%)
Not reported
4 (13%)
4 (21%)
6 (13%)
7 (12%)

*More than one answer was possible for the question

Lavis et al. Implementation Science 2008 3:54   doi:10.1186/1748-5908-3-54

Open Data